Company
Every investor coverage indicates participated in a round World Health Organization raised.
Companies World Health Organization acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
Stories naming World Health Organization. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Vaxxas reports encouraging interim Phase I results for its needle-free microarray-patch COVID-19 vaccine, with strong antibody responses and no serious adverse events, ahead of planned regulatory applications in Australia and the US.
Vaxxas has appointed 23-year Pfizer veteran Dr Rochelle Chaiken as chief medical officer; the announcement also recaps the vaccine-patch company's early backing by OneVentures, Brandon Capital and others.